582 Companies
BioNTech SE, a German biotechnology company, is on a mission to develop and commercialize immunotherapies for various infectious diseases and cancer. The company's FixVac product candidates are mak...
BioNTech SE Annual Report 2023Toronto-based Intellipharmaceutics is a pioneering company in the global pharmaceutical industry, having been established in 1998. A key aspect of Intellipharmaceutics' offerings is its proprietary...
IntelliPharmaCeutics International Inc. Annual Report 2019Turning Point is a precision oncology company with a focus on creating investigational drugs to improve cancer therapies. The company's lead drug candidate, repotrectinib, is a kinase inhibitor tha...
Turning Point Therapeutics, Inc. Annual Report 2020A clinical-stage immuno-oncology company known as Agenus Inc. has been making waves in the United States and around the world with its discovery and development of immuno-oncology products. This in...
Agenus Annual Report 2023Cellect Biotechnology Ltd. is a company focused on enabling regenerative medicine through the mass enrichment of stem cells. Founded in 2011, its goal is to make quality stem cells easily available...
Cellect Biotechnology Ltd. Annual Report 2020Arbutus Biopharma Corporation, a Pennsylvania-based biopharmaceutical firm, announced its dedication to developing innovative therapeutics for chronic Hepatitis B virus infection, SARS-CoV-2, and o...
Arbutus Biopharma Annual Report 2023PTC Therapeutics, a biopharmaceutical firm, is making strides in developing and bringing novel drugs to market for those suffering from obscure ailments. The company boasts a wide-ranging pipeline,...
PTC Therapeutics Annual Report 2023Akcea Therapeutics, a biopharmaceutical company, is focused on developing and commercializing treatments for serious and rare diseases. Its flagship products, TEGSEDI and WAYLIVRA, are already appr...
Akcea Therapeutics, Inc. Annual Report 2018Sarepta Therapeutics, Inc., a Cambridge, Massachusetts-based biopharmaceutical company, has dedicated itself to the development and discovery of RNA-targeted therapeutics, genetic therapeutic modal...
Sarepta Therapeutics Annual Report 2023Regulus Therapeutics, a clinical stage biopharmaceutical company headquartered in San Diego, California, is spearheading the discovery and development of drugs that target microRNAs to treat a rang...
Regulus Therapeutics Inc Annual Report 2023Hemogenyx Pharmaceuticals is a UK-based preclinical-stage biotech company focused on developing therapies and treatments for blood diseases, particularly for the bone marrow/hematopoietic stem cell...
Hemogenyx Pharmaceuticals Plc Annual Report 2023Magenta Therapeutics, a leader in biotechnology focused on stem cell transplantation, is making significant strides in unlocking the curative potential of stem cell transplant for patients with gen...
Magenta Therapeutics Annual Report 2021Late-stage immuno-oncology company, OncoSec Medical Incorporated, is honing in on the development and commercialization of intra-tumoral DNA-based therapeutics aimed to boost anti-tumor immune resp...
OncoSec Medical Incorporated Annual Report 2021Aytu Biopharma, Inc., a Colorado-based specialty pharmaceutical company, is making waves in the world of therapeutics and consumer healthcare products. The company is dedicated to developing and co...
Aytu Biopharma Annual Report 2023San Diego-based biopharmaceutical company, Fate Therapeutics, Inc., is currently in the clinical stages of developing programmed cellular immunotherapies designed to treat cancer and immune disorde...
Fate Therapeutics Annual Report 2023